MAGPLASMA, INC. — Department of Homeland Security SBIR Phase II: NEW SBIR CONTRACT FOR DHS211-004 SBIR PHASE II CRPP ON VEHICLE INFECTIOUS DISEASES PROTECT
MAGPLASMA, INC. — SBIR Phase II award from Department of Homeland Security.
Phase II SBIR prototype / development signal
- Phase II is where Department of Homeland Security funds deeper R&D after feasibility. Incumbents with Phase II history are serious competitors on adjacent topics.
- Use this award as past-performance context and to map customer organizations for STRATFI/TACFI-style transition planning.
- Obligated amount $248,963. Cross-check similar awards in the same agency and technology tags for going-rate context.
- Tagged technology areas: Human Performance & Medical. Follow those hubs for open topics and peer winners in the same cluster.
Summary
MagPlasma, Inc. received a Phase II SBIR award of about $249,000 from the Department of Homeland Security. The project develops technology to protect vehicles against infectious diseases.
- Amount
- $248,963
- Agency
- Department of Homeland Security · Office of Procurement Operations
- Program / Phase
- SBIR · Phase II
- NAICS
- 541715 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
- Place of performance
- MI
- Period
- 2024-09-24 → 2026-09-20
Technology domains
Description
NEW SBIR CONTRACT FOR DHS211-004 SBIR PHASE II CRPP ON VEHICLE INFECTIOUS DISEASES PROTECTION.